Navigation Links
Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
Date:1/30/2009

org)

About Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies Inc. (http://www.stemedica.com) is a specialty biopharmaceutical company that is committed to the development and manufacture of best-in-class adult stem cells for use by approved research institutions and hospitals for pre-clinical and clinical studies. Within the United States, the Company is currently developing regulatory pathways for stroke, traumatic brain injury and wound repair. Outside the United States, Stemedica provides its adult stem cells to hospitals and research centers that are conducting studies under protocols approved by appropriate regulatory agencies. These studies are focused on the treatment of neurodegenerative disease, sight restoration and wound repair. Stemedica is headquartered in San Diego, California.

From more information regarding Stemedica Cell Technologies or the Dr. Michael Bayer appointment, contact Dave McGuigan at dmcguigan (at) stemedica (dot) com.

# # #

Read the full story at http://www.prweb.com/releases/stemedica/adult-stem-cell-research/prweb1936934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Nektar Announces Retirement of Irwin Lerner from Board of Directors
2. Cardica Announces Fiscal 2009 Second Quarter Financial Results
3. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
4. Omnitura Therapeutics Announces Private Placement Financing
5. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
6. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
7. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
8. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
9. Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project
10. Medarex Announces Allowance of Investigational New Drug Application for Companys First Antibody-Drug Conjugate, MDX-1203
11. XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
(Date:8/3/2015)... At the 11th hour, ... the shortfall of Jude Liversage,s campaign so ... first time.      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ... The Selective Dorsal Rhizotomy (SDR) procedure reduced ... out his wish to kick a ball around like ...
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... TLD5000 diaphragm vacuum pumps to its comprehensive line of analytical laboratory equipment. With ... valves, these versatile pumps provide a chemically resistant and maintenance-free solution for a ...
(Date:7/30/2015)... Marshall, MN (PRWEB) , ... July 31, 2015 , ... ... Ralco Enrichment Center at the Lyon County Fair to be held August 5-9 in ... more about where their meals come from and how agriculture impacts their daily lives. ...
Breaking Biology Technology:Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Sterlitech Launches New Line of Vacuum Pumps 2Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2
... , ... , ... , , , ... ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM) 2Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM) 3Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM) 4Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 2Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 3Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 4Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 5Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 6Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 7Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 8Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 2Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 3Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 4Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 5Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 6Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 7Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 8Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 9Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 10Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform 11
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... a group of ancient enzymes adapted to substantial changes ... billion years, providing evidence that life on Early Earth ... the cooler, less acidic global environment that exists today. ... enzymes known as thioredoxin were chemically stable at temperatures ...
... Much of the risk of developing incontinence before ... can explain half of people,s susceptibility to urinary incontinence, ... and Karolinska Institutet (Sweden) reveals. Urinary incontinence is ... three affected at some point in life. Incontinence, overactive ...
... prolong his youth is showing promise as a way ... An environment of pure oxygen at three-and-a-half times normal ... natural compound already shown to kill cancerous cells, researchers ... recently reported in the journal Anticancer Research . ...
Cached Biology News:Protein adaptation shows that life on early earth lived in a hot, acidic environment 2Protein adaptation shows that life on early earth lived in a hot, acidic environment 3Protein adaptation shows that life on early earth lived in a hot, acidic environment 4Genes an important factor in urinary incontinence 2High dose of oxygen enhances natural cancer treatment 2